Advanced search

The clinical safety of H-1-receptor antagonists : an EAACI position paper

(1996) ALLERGY. 51(10). p.666-675
Author
Organization
Keywords
CENTRAL-NERVOUS-SYSTEM, TORSADE-DE-POINTES, PSYCHOMETRIC TEST-PERFORMANCE, HISTAMINE-INDUCED WHEALS, CAR DRIVING PERFORMANCE, ASTEMIZOLE OVERDOSE, DAYTIME SLEEPINESS, DOUBLE-BLIND, PHARMACOLOGICAL PROPERTIES, VENTRICULAR-TACHYCARDIA

Citation

Please use this url to cite or link to this publication:

Chicago
Passalacqua, G, J Bousquet, Claus Bachert, M Church, R Davies, S Durham, F Horak, et al. 1996. “The Clinical Safety of H-1-receptor Antagonists : an EAACI Position Paper.” Allergy 51 (10): 666–675.
APA
Passalacqua, G., Bousquet, J., Bachert, C., Church, M., Davies, R., Durham, S., Horak, F., et al. (1996). The clinical safety of H-1-receptor antagonists : an EAACI position paper. ALLERGY, 51(10), 666–675.
Vancouver
1.
Passalacqua G, Bousquet J, Bachert C, Church M, Davies R, Durham S, et al. The clinical safety of H-1-receptor antagonists : an EAACI position paper. ALLERGY. 1996;51(10):666–75.
MLA
Passalacqua, G, J Bousquet, Claus Bachert, et al. “The Clinical Safety of H-1-receptor Antagonists : an EAACI Position Paper.” ALLERGY 51.10 (1996): 666–675. Print.
@article{263096,
  author       = {Passalacqua, G and Bousquet, J and Bachert, Claus and Church, M and Davies, R and Durham, S and Horak, F and Kontou-Fili, K and Malling, H and Van Cauwenberge, Paul and Canonica, GW},
  issn         = {0105-4538},
  journal      = {ALLERGY},
  keywords     = {CENTRAL-NERVOUS-SYSTEM,TORSADE-DE-POINTES,PSYCHOMETRIC TEST-PERFORMANCE,HISTAMINE-INDUCED WHEALS,CAR DRIVING PERFORMANCE,ASTEMIZOLE OVERDOSE,DAYTIME SLEEPINESS,DOUBLE-BLIND,PHARMACOLOGICAL PROPERTIES,VENTRICULAR-TACHYCARDIA},
  language     = {eng},
  number       = {10},
  pages        = {666--675},
  title        = {The clinical safety of H-1-receptor antagonists : an EAACI position paper},
  volume       = {51},
  year         = {1996},
}